September 22, 2010 - A new intravascular imaging system will be highlighted at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The C7-XR optical coherence tomography (OCT) platform, made by St. Jude Medical, offers physicians a new tool for intravascular lesion assessment.

September 22, 2010 – Trial data indicate that a new stent may be a safer solution to treat heart attack patients. The Apposition II study found that the Stentys self-apposing stent helps reduce the risk of malapposition in patients who have suffered an acute myocardial infarction (AMI).

The 23rd annual International Symposium on Endovascular Therapy (ISET) will take place from Jan. 16-20, 2011 in Miami Beach. At the meeting, more than 1,500 members of the endovascular community-including physicians, researchers, nurses and professionals from around the world-will discuss the field’s controversies and advances.

September 21, 2010 – A new drug-eluting stent system has received CE mark approval for diabetic patients and those experiencing a heart attack.

The PROMUS element everolimus-eluting stent system, made by Boston Scientific, can be used in patients with concomitant diabetes mellitus as well as those suffering from an acute myocardial infarction (AMI).

September 21, 2010 - Patent infringement claims by St. Jude Medical Systems against the Volcano Corporation are without merit, the company said Tuesday.

September 21, 2010 – Two companies announced that they have entered into a distribution agreement in the United States. The agreement allows Vascular Solutions to distribute Shepherd Scientific’s Angio Assist and Teirstein Edge products.

September 21, 2010 – The first patients have been enrolled in a trial testing a new treatment for refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is designed to assess the clinical efficacy of the Neovasc Reducer. The goal is to minimize angina symptoms after six months.

September 21, 2010 – Ventricular assist devices (VADs) can restore normal hemodynamics and support recovery of native cardiac function after acute myocardial infarction (AMI), according to a study published in the September 2010 issue of The Annals of Thoracic Surgery. The study looked at patients who used Abiomed’s AB5000 Ventricular Assist Device.

September 20, 2010 - Results for the first-in-human study for a robotic cath lab navigation system will be announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference. Corindus Vascular Robotics will present information on the study involving its CorPath 200 System.

September 20, 2010 – The U.S. Food and Drug Administration (FDA) has approved the Integrity coronary stent system, which is said to offer better delivery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now